MedTrace Logo

Immediate Effect of Proponent-Nasal-Spray on Unspecific Discomfort in the Nose

NCT03251066 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2017-08-21

No results posted yet for this study

Summary

Investigation of the immediate effect on subjective relief of symptoms by Proponent - Nasal - Spray after a one time administration (following a single dose administration in each nostril) in an open, not randomised, non-blinded single centre observation study on 40 volunteers between 18-75 years of age with an unspecific discomfort in the nose such as enhanced nasal discharge/ secretion (runny nose), congested nose, sneezing, itchy nose or feeling of a dry nose.

Conditions

  • Unspecified Disorder of Nose and Nasal Sinuses

Interventions

OTHER

Proponent Nasal Spray

The medical device consists of a Saline solution containing sodium propionate which is administered as single dose

Sponsors & Collaborators

  • PRECLIN Biosystems AG

    lead INDUSTRY

Principal Investigators

  • Soyka Michael, MD · ORL, USZ

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-27
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03251066 on ClinicalTrials.gov